PL3328397T3 - Kompozycje egzosomów oraz sposoby ich wytwarzania i stosowania do regulowania i kondycjonowania skóry i włosów - Google Patents

Kompozycje egzosomów oraz sposoby ich wytwarzania i stosowania do regulowania i kondycjonowania skóry i włosów

Info

Publication number
PL3328397T3
PL3328397T3 PL16833569.3T PL16833569T PL3328397T3 PL 3328397 T3 PL3328397 T3 PL 3328397T3 PL 16833569 T PL16833569 T PL 16833569T PL 3328397 T3 PL3328397 T3 PL 3328397T3
Authority
PL
Poland
Prior art keywords
hair
regulating
preparation
methods
conditioning skin
Prior art date
Application number
PL16833569.3T
Other languages
English (en)
Inventor
John W. Ludlow
Benjamin Buehrer
Peter Pieraccini
Original Assignee
Exotropin, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exotropin, Llc filed Critical Exotropin, Llc
Publication of PL3328397T3 publication Critical patent/PL3328397T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
PL16833569.3T 2015-07-31 2016-07-28 Kompozycje egzosomów oraz sposoby ich wytwarzania i stosowania do regulowania i kondycjonowania skóry i włosów PL3328397T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562199696P 2015-07-31 2015-07-31
PCT/US2016/044458 WO2017023690A1 (en) 2015-07-31 2016-07-28 Exosome compositions and methods for preparation and use thereof for regulating and conditioning skin and hair

Publications (1)

Publication Number Publication Date
PL3328397T3 true PL3328397T3 (pl) 2023-10-16

Family

ID=57943605

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16833569.3T PL3328397T3 (pl) 2015-07-31 2016-07-28 Kompozycje egzosomów oraz sposoby ich wytwarzania i stosowania do regulowania i kondycjonowania skóry i włosów

Country Status (11)

Country Link
US (2) US20180177828A1 (pl)
EP (2) EP3328403A4 (pl)
JP (2) JP6719559B2 (pl)
CA (2) CA2993227C (pl)
ES (1) ES2952050T3 (pl)
HR (1) HRP20230865T1 (pl)
HU (1) HUE063486T2 (pl)
PL (1) PL3328397T3 (pl)
RS (1) RS64469B1 (pl)
SM (1) SMT202300249T1 (pl)
WO (2) WO2017023689A1 (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11596656B2 (en) * 2016-08-23 2023-03-07 Albert Einstein College Of Medicine Stem cell-produced microvesicles for treating tendon pathologies
CN107080753A (zh) * 2017-04-20 2017-08-22 深圳市赛欧细胞生物科技有限公司 一种人脐带间充质干细胞源外泌体的美容制剂
CN107006452A (zh) * 2017-04-20 2017-08-04 深圳市赛欧细胞生物科技有限公司 一种人脐带间充质干细胞源外泌体冻干保存方法及其应用
CN107245472B (zh) * 2017-06-08 2021-08-06 北京智能宝生物科技有限公司 一种人间充质干细胞外泌体冻干粉的制备方法、使用方法
CN110869033B (zh) * 2017-06-30 2023-05-09 韩国外泌体生技有限公司 包含干细胞来源外排体作为有效成分的组合物用于抑制或减轻瘙痒的用途
KR20190003316A (ko) 2017-06-30 2019-01-09 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부염 개선 용도
WO2019004738A2 (ko) * 2017-06-30 2019-01-03 주식회사 엑소코바이오 지방줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부염 개선 용도
US11590175B2 (en) 2017-08-23 2023-02-28 Merakris Therapeutics Llc Compositions containing amniotic components and methods for preparation and use thereof
US12281330B2 (en) 2017-09-11 2025-04-22 SymbioCellTech Adaptation of hollow-fiber-based cell culture technology for the manufacturing of (1) neo-islets, employed for the treatment of type 1 and type 2 diabetes mellitus, and (2) the generation of exosomes from various cell types, used in the treatment of different organ injuries and diseases
JP2021503286A (ja) * 2017-11-16 2021-02-12 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Ｍｓｃ由来エキソソームの製造方法
WO2019103381A1 (ko) * 2017-11-24 2019-05-31 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
KR20190060646A (ko) * 2017-11-24 2019-06-03 주식회사 엑소코바이오 줄기세포 유래의 엑소좀 및/또는 세포외 소포체를 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
KR102039302B1 (ko) * 2017-11-24 2019-10-31 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 조성물의 피부장벽 강화 내지 기능 개선 용도
AU2018386209B2 (en) 2017-12-14 2024-10-24 Mayo Foundation For Medical Education And Research Purified exosome products, method of making, and methods of using
WO2019139762A1 (en) * 2018-01-09 2019-07-18 Zen-Bio, Inc. Exosome compositions and use thereof for joint disorders and diseases
JP7474702B2 (ja) 2018-03-28 2024-04-25 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法
WO2019213518A1 (en) * 2018-05-04 2019-11-07 Figene, Llc Pain-reducing effects of fibroblasts and treatment of pain
RU2710368C2 (ru) * 2018-05-29 2019-12-26 Станислав Евгеньевич Волчков Способ получения и концентрирования микроРНК-содержащих экзосом мультипотентных мезенхимально-стромальных клеток для применения в косметических и лекарственных средствах для стимуляции регенеративных процессов и замедления процессов старения
US12453743B2 (en) 2018-05-30 2025-10-28 Direct Biologics, Llc Mesenchymal stem cell (MSC) growth factor and extracellular vesicle preparation in frozen or powdered form and methods of use
WO2019231133A1 (ko) * 2018-05-31 2019-12-05 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
KR102646145B1 (ko) * 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
CN108715834B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种富含cd41+、cd81+微囊的血小板裂解液制备方法
KR102176845B1 (ko) * 2018-10-02 2020-11-10 주식회사 스템온 유도된 엑소좀을 포함하는 피부 재생 및 상처 치유용 조성물
KR20210137026A (ko) 2019-02-07 2021-11-17 다이렉트 바이오로직스 엘엘씨 중간엽 줄기세포 엑소좀, 활액 중간엽 줄기세포 및 스캐폴드의 조합을 이용한 골관절염 치료 방법
JP2022522357A (ja) 2019-02-28 2022-04-18 メラクリス セラピューティクス リミテッド ライアビリティ カンパニー 羊水由来の細胞外小胞及び創傷治癒のためのその使用
WO2020180311A1 (en) * 2019-03-06 2020-09-10 Zen-Bio, Inc. Plant-based exosome compositions and use thereof for rejuvenating skin
EP3962502A4 (en) * 2019-04-29 2023-01-04 Direct Biologics LLC Method for the treatment of periodontal disease using characterized mesenchymal stem cell growth factors and exosomes
EP3999083A4 (en) 2019-07-18 2023-07-26 Direct Biologics LLC Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
JP2021040551A (ja) * 2019-09-11 2021-03-18 富士フイルム株式会社 培地組成物、キット、間葉系幹細胞組成物の製造方法、間葉系幹細胞組成物、間葉系幹細胞、細胞培養上清および細胞外小胞
CN110559254A (zh) * 2019-10-20 2019-12-13 张新梅 一种外泌体组合物、其制备方法及应用
CN114641300A (zh) * 2019-11-04 2022-06-17 奥马尔·穆罕默德·萨拉赫·埃尔丁·艾哈迈德·埃尔图基 用于涂覆和干燥异源干细胞衍生的细胞外囊泡的方法
CN110721198A (zh) * 2019-11-08 2020-01-24 赵凯 一种预防癫痫产生脑损伤的外泌体喷雾的制作工艺
JP7741559B2 (ja) * 2020-01-20 2025-09-18 イーブイ、セル、バイオテック、（コアンチョウ）、カンパニー、リミテッド 細胞外小胞及びその皮膚製品における使用
JP7778377B2 (ja) * 2020-01-20 2025-12-02 イーブイ、セル、バイオテック、（コアンチョウ）、カンパニー、リミテッド 小胞及びその使用
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
US20230159932A1 (en) 2020-04-22 2023-05-25 Direct Biologics Llc Methods and compositions for treating inflammatory conditions associated with infectious disease
WO2022158816A1 (ko) * 2021-01-20 2022-07-28 성균관대학교산학협력단 줄기세포 유래 엑소좀, 히알루론산, 및 bdde를 포함하는 피부 주름개선용 필러 조성물 및 이의 제조 방법
KR102368442B1 (ko) * 2021-02-19 2022-02-28 주식회사 엑소코바이오 생리활성이 강화된 엑소좀의 생산방법 및 이의 응용
TW202235614A (zh) * 2021-03-11 2022-09-16 長新生醫國際股份有限公司 幹細胞凍乾粉之製造方法
CN113041259B (zh) * 2021-03-23 2023-05-12 哈尔滨科技实业开发有限公司 牙髓干细胞外泌体制剂及制备方法和应用
BR112023020245A2 (pt) * 2021-03-31 2023-12-19 Nutraceutical Wellness Inc Composição, métodos para estimular o crescimento do cabelo e para promover o crescimento do cabelo, kit e uso de uma composição
CN113384518A (zh) * 2021-07-27 2021-09-14 山西遗传资源细胞库有限公司 一种干细胞外泌体应用于面膜的方法
JPWO2023079655A1 (pl) * 2021-11-04 2023-05-11
CN113940912B (zh) * 2021-12-09 2024-04-16 深圳市泓浩生物科技有限公司 抗衰老的组合物及其应用
CN116099056A (zh) * 2023-04-07 2023-05-12 云南云科特色植物提取实验室有限公司 一种含仿生纹理结构的人工皮肤及其制备方法
CN116410918B (zh) * 2023-06-12 2023-08-25 成都诺医德医学检验实验室有限公司 一种皮肤类器官外泌体及其制备方法和应用
WO2025030027A1 (en) * 2023-08-03 2025-02-06 Wisconsin Alumni Research Foundation Extracellular vesicle therapy to treat orthopedic injury
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
CN118576721A (zh) * 2024-05-27 2024-09-03 深圳市中安康华生物科技有限公司 一种外泌体复合生物制剂及其制备方法与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348945A (en) * 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5593682A (en) * 1995-12-29 1997-01-14 Eastman Chemical Company Skin treating composition
AT409379B (de) * 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP2004331602A (ja) * 2003-05-09 2004-11-25 Arysta Lifescience Corp 皮膚外用剤
EP1514539A3 (en) * 2003-05-14 2005-05-04 Signal Investment & Management Co. Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
US20060143782A1 (en) * 2004-10-07 2006-07-06 Sherry Ajluni Glove with skin lotion
US8022037B2 (en) * 2007-01-08 2011-09-20 University Of Southern California Skin wound healing compositions and methods of use thereof
AU2009215934C1 (en) * 2008-02-22 2014-05-08 Agency For Science, Technology And Research (A*Star) Mesenchymal stem cell particles
WO2012026712A2 (ko) * 2010-08-23 2012-03-01 주식회사 강스템홀딩스 Ｎｏｄ２의 아고니스트를 처리한 줄기세포 또는 그 배양물을 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약학조성물
JP5911874B2 (ja) * 2010-10-18 2016-04-27 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 発毛を促進又は増強するためのエキソソームの使用
US9119974B2 (en) * 2011-03-04 2015-09-01 Ahmed H. Al-Qahtani Skin cream
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
JP3171007U (ja) * 2011-06-28 2011-10-13 ヘルスアシスト株式会社 腕肩美容パックシート
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
EP2687219A1 (en) * 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
DK2972193T3 (da) * 2013-03-13 2020-03-23 Univ Miami Fremgangsmåde til isolation og oprensning af mikrovesikler fra cellekultursupernatanter og biologiske fluider
WO2014197747A1 (en) * 2013-06-05 2014-12-11 The Trustees Of Columbia University In The City Of New York Exosomes for orofacial diagnostics and therapeutics
JP2015101541A (ja) * 2013-11-21 2015-06-04 ポーラ化成工業株式会社 皮膚関連酵素活性化剤
JP6253361B2 (ja) * 2013-11-21 2017-12-27 ポーラ化成工業株式会社 皮膚外用剤
US9464272B2 (en) * 2013-12-12 2016-10-11 Stemnion, Inc. Cell-derived composition
CN104488850B (zh) * 2014-11-28 2016-11-02 广州赛莱拉干细胞科技股份有限公司 一种制备人羊膜间充质干细胞外泌体冻干粉的方法

Also Published As

Publication number Publication date
JP2018522593A (ja) 2018-08-16
US20180177828A1 (en) 2018-06-28
EP3328397A1 (en) 2018-06-06
EP3328397A4 (en) 2019-04-03
EP3328397B1 (en) 2023-07-12
EP3328403A4 (en) 2019-04-17
HUE063486T2 (hu) 2024-01-28
CA2993224A1 (en) 2017-02-09
HRP20230865T1 (hr) 2023-11-10
JP2018522071A (ja) 2018-08-09
ES2952050T3 (es) 2023-10-26
WO2017023690A1 (en) 2017-02-09
SMT202300249T1 (it) 2023-09-06
EP3328397C0 (en) 2023-07-12
CA2993227C (en) 2020-07-21
EP3328403A1 (en) 2018-06-06
WO2017023689A1 (en) 2017-02-09
RS64469B1 (sr) 2023-09-29
JP6719559B2 (ja) 2020-07-08
JP6980955B2 (ja) 2021-12-15
US20180147420A1 (en) 2018-05-31
CA2993227A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
HUE063486T2 (hu) Exoszóma kompozíciók és eljárások azok elõállítására és alkalmazásukra a bõr és a haj állapotának szabályozására és kondicionálására
ZA201706798B (en) Hair treatment compositions
PL3001809T3 (pl) Sposób odżywiania włosów i skóry
PL3062797T3 (pl) Kompozycje zmniejszające wypadanie włosów i/lub zwiększające odrastanie włosów
EP3240523A4 (en) Washing and conditioning hair composition
GB201621818D0 (en) Cosmetic composition and use thereof
GB201616070D0 (en) Skin cosmetic
SG11202002414SA (en) Hair care compositions and methods
ZA201707527B (en) Hair care formulation
PL3367995T3 (pl) Kompozycja do pielęgnacji skóry oraz jej sposób
ZA202000502B (en) Cosmetic compositions and methods of use
IL282473A (en) A cosmetic method and the use of medicine to reduce fat
ZA202001837B (en) Hair conditioning composition
ZA201803011B (en) Hair care composition
SG11201902966SA (en) Hair dressing composition
SG11201710686PA (en) Hair treatment agent
GB201611406D0 (en) Skin care composition and method thereof
SG11201605935RA (en) Hair cosmetic composition and method for using same
ZA201807258B (en) Method of conditioning hair
PL3478260T3 (pl) Kompozycja do pielęgnacji skóry i jej zastosowanie
SG10201608651XA (en) Hair cosmetic composition
SG10201604138SA (en) Hair cosmetic composition
GB2522647B (en) Hair smoothing and conditioning apparatus
SG11201607201TA (en) Hair cosmetic composition
GB201508518D0 (en) Hair treatment compositions and methods